NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.

Venook, Alan P; Arcila, Maria E; Benson, Al B; Berry, Donald A; Camidge, David Ross; Carlson, Robert W; Choueiri, Toni K; Guild, Valerie; Kalemkerian, Gregory P; Kurzrock, Razelle; Lovly, Christine M; McKee, Amy E; Morgan, Robert J; Olszanski, Anthony J; Redman, Mary W; Stearns, Vered; McClure, Joan; Birkeland, Marian L

Venook, Alan P; Arcila, Maria E; Benson, Al B; Berry, Donald A; Camidge, David Ross; Carlson, Robert W; Choueiri, Toni K; Guild, Valerie; Kalemkerian, Gregory P; Kurzrock, Razelle; Lovly, Christine M; McKee, Amy E; Morgan, Robert J; Olszanski, Anthony J; Redman, Mary W; Stearns, Vered; McClure, Joan; Birkeland, Marian L.

J Natl Compr Canc Netw ; 12(11): 1629-49, 2014 Nov.

Article in En | MEDLINE | ID: mdl-25361808

Subject(s)

Biomarkers/metabolism; Neoplasms/drug therapy; Neoplasms/metabolism; Clinical Trials as Topic; Humans; Precision Medicine/methods; Research Design

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google